11 March, 2016 by The TZ Newswire Staff Comments Off on Regeneron/Sanofi Drug Beats Humira In Rheumatoid Arthritis Trial
Regeneron/Sanofi Drug Beats Humira In Rheumatoid Arthritis Trial
A drug candidate that Regeneron Pharmaceuticals (REGN) and Sanofi (SNY) jointly developed has beaten AbbVie’s (ABBV) best-selling rheumatoid-arthritis (RA) drug in a late-stage study, the companies said Friday.
11 March, 2016 by The TZ Newswire Staff Comments Off on Bond Report: Treasury yields post longest streak of increases in 3 years
Bond Report: Treasury yields post longest streak of increases in 3 years
Treasury prices tumbled Friday, pushing yields higher for the fourth straight week—the longest streak of rising yields since May 2013—as a rally in riskier assets, including equities and oil, led investors to sell haven assets.
read more
11 March, 2016 by The TZ Newswire Staff Comments Off on Personal Finance Daily: Why you’re having trouble sleeping, and the biggest life regrets
Personal Finance Daily: Why you’re having trouble sleeping, and the biggest life regrets
Why you’re having trouble sleeping, and what older Americans recount as their biggest life regret.
read more
11 March, 2016 by The TZ Newswire Staff Comments Off on Analyst Sees Big Upside For Coke, Which Trades Near High
Analyst Sees Big Upside For Coke, Which Trades Near High
Venerable blue chip Coca-Cola (KO) is trading near a new high after raising its dividend and being on the receiving end of kind words from an analyst.
11 March, 2016 by The TZ Newswire Staff Comments Off on Portland Hedge Fund About To Learn That Ponzi Schemes Are Neither Retro Nor Hip
Portland Hedge Fund About To Learn That Ponzi Schemes Are Neither Retro Nor Hip
11 March, 2016 by The TZ Newswire Staff Comments Off on The Week Ahead: Fed mulls rate hike
The Week Ahead: Fed mulls rate hike
CNBC’s Michelle Caruso-Cabrera looks ahead to next week’s market-moving events, including earnings from Valeant and FedEx.
11 March, 2016 by The TZ Newswire Staff Comments Off on Kilduff: $18 oil not off the table
Kilduff: $18 oil not off the table
John Kilduff and other other energy experts mull over whether oil has hit a bottom or not, amid promising news for oil investors.